title: FDA Advisory Committee reviews safety of boceprevir.
mesh_terms: D000740:Anemia / Q000139:chemically induced*; D001853:Bone Marrow / Q000187:drug effects; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D011392:Proline / Q000009:adverse effects / Q000031:analogs & derivatives*; D011480:Protease Inhibitors / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D011480:Protease Inhibitors; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline